Elevated serum fibrin-monomer levels are associated with high long-term cerebrovascular event rates in acute ischemic stroke patients

Circulation Journal

Volumn 71, Issue 10, 2007, Pages 1573-1579

  Tamura, Harutoshi ^a   Hirono, Osamu ^a   Okuyama, Hidenobu ^a   Liu, Ling ^a   Nishiyama, Satoshi ^a   Takeishi, Yasuchika ^a   Kayama, Takamasa ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Acute ischemic stroke; Fibrin monomer; Prognosis

Indexed keywords

FIBRIN MONOMER;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYSIS; FOLLOW UP; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; THROMBOGENESIS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECURRENCE; RISK FACTORS; STROKE; THROMBOPHILIA;

EID: 34948845700     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1573     Document Type: Article

References (34)

1. Okuyama H, Hirono O, Liu L, Takeishi Y, Kayama T, Kubota I. Higher levels of serum fibrin-monomer reflect hypercoagulable state and thrombus formation in the left atrial appendage in patients with acute ischemic stroke. Circ J 2006; 70: 971-976.
2. Blomback B, Bark N. Fibrinopeptide and fibrin gel structure. Biophys Chem 2004; 112: 147-151.
3. Dempfle CE. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state. Thromb Haemost 1999; 82: 673-683.
4. Hong M, Wei W, Li H, Yang R, Yang Y. Association of fibrin monomer polymerization function, cerebrovascular risk factors and ischemic cerebrovascular disease in old people. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 131-133.
5. Deguchi K, Deguchi A, Wada H, Murashima S. Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons. Semin Thromb Hemost 2000; 26: 23-27.
6. Takano K, Yamaguchi T, Kato H, Omae T. Activation of coagulation in acute cardioembolic stroke. Stroke 1991; 22: 12-16.
7. Takano K, Yamaguchi T, Uchida K. Markers of a hypercoagulable state following acute ischemic stroke. Stroke 1992; 23: 194-198.
8. Soda T, Nakayasu H, Meda M, Kusumi M, Kowa H, Awaki E, et al. Stroke recurrence within the first year following cerebral infarction: Tottori University Lacunar Infarction Prognosis Study (TULIPS). Acta Neurol Scand 2004; 110: 343-349.
9. Yokota C, Minematsu K, Hasegawa Y, Yamaguchi T. Long-term prognosis, by stroke subtypes, after a first-ever stroke: A hospital-based study over a 20-year period. Cerebrovasc Dis 2004; 18: 111-116.
10. National Institute of Neurological Disorders and Stroke. Special report: Classification of cerebrovascular diseases III. Stroke 1990; 21: 637-676.
11. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: A clinical examination scale. Stroke 1989; 20: 864-870.
12. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
13. Blum A, Reisner S, Farbstein Y. Transesophageal echocardiography (TEE) vs transthoracic echocardiography (TTE) in assessing cardiovascular sources of emboli in patients with acute ischemic stroke. Med Sci Monit 2004; 10: 521-523.
14. Narumiya T, Sakamaki T, Sato Y, Kanmatsuse K. Relationship between left atrial appendage function and left atrial thrombus in patients with nonvalvular chronic atrial fibrillation and atrial flutter. Circ J 2003; 67: 68-72.
15. Oyama R, Murata K, Tanaka N, Takai A, Ueda K, Liu J, et al. Is the ratio of transmitral peak E-wave velocity to color flow propagation velocity useful for evaluating the severity of heart failure in atrial fibrillation? Circ J 2004; 68: 132-138.
16. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994; 23: 307-316.
17. Fatkin D, Feneley MP. Patterns of Doppler-measured blood flow velocity in the normal and fibrillating human left atrial appendage. Am Heart J 1996; 132: 995-1003.
18. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994; 331: 1474-1479.
19. Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992; 326: 221-225.
20. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
21. European Carotid Surgery Trialists Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379-1387.
22. U-King-Im JM, Trivedi RA, Cross JJ, Higgins NJ, Hollingworth W, Graves M, et al. Measuring carotid stenosis on contrast-enhanced magnetic resonance angiography: Diagnostic performance and reproducibility of 3 different methods. Stroke 2004; 35: 2083-2088.
23. Hamano A, Umeda M, Ueno Y, Tanaka S, Mimuro J, Sakata Y. Latex immunoturbidimetric assay for soluble fibrin complex. Clin Chem 2005; 51: 183-188.
24. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001; 32: 133-138.
25. Urabe T, Tanaka R, Noda K, Mizuno Y. Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: Usefulness of coagulation markers for evaluation of efficacy. J Thromb Thrombolysis 2002; 13: 155-160.
26. Ageno W, Finazzi S, Steidl L, Biotti MG, Mera V, Melzi D'Eril G, et al. Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 2002; 162: 2589-2593.
27. Vene N, Mavri A, Kosmelj K, Stegnar M. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost 2003; 90: 973-975.
28. Kelly J, Rudd A, Lewis RR, Coshall C, Parmar K, Moody A, et al. Screening for proximal deep vein thrombosis after acute ischemic stroke: A prospective study using clinical factors and plasma D-dimers. J Thromb Haemost 2004; 2: 1321-1326.
29. Nozawa T, Inoue H, Izawa A, Okumura K, Jong-dae L, Shimizu A, at al. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation. Circ J 2004; 68: 29-34.
30. Fassbender K, Dempfle CE, Mielke O, Schwartz A, Daffertshofer M, Eschenfelder C, et al. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke 1999; 30: 2101-2104.
31. Palasik W, Fiszer U, Lechowicz W, Czartoryska B, Krzesiewicz M, Lugowska A. Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters. Eur Neurol 2005; 53: 188-193.
32. Tamam Y, Iltumur K, Apak I. Assessment of acute phase proteins in acute ischemic stroke. Tohoku J Exp Med 2005; 206: 91-98.
33. Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A multicenter, prospective, randomized trial: Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke 2000; 31: 817-821.
34. Yasaka M, Minematsu K, Yamaguchi T. Optimal intensity of international normalized ratio in Warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 2001; 40: 1183-1188.